跳至主要内容
临床试验/NCT02348944
NCT02348944已完成不适用

Evaluation of Biological Variability in Cartilage Specific Biomarkers (Coll2-1, Coll2-1NO2, FIB3-1 and FIB 3-2) in Healthy Volunteers.

Artialis1 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2013年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Artialis
入组人数
15
试验地点
1
主要终点
Variation of serum and urine sample between baseline, weeks 2, 16, 52 and 68 to assess intra-individual biological variability of cartilage-specific biomarkers Coll2-1/Coll2-1NO2 / FIB3-1 and FIB3-2.

研究概览

简要总结

The purposes of the study are to assess intra individual biological variability of serum and urinary cartilage specific biomarkers and define the best standardized conditions for blood and urine sampling in the frame of biomarkers dosage.

详细描述

To assess intra individual biological variability of serum and urinary cartilage specific biomarkers and define the best standardized conditions for blood and urine sampling in the frame of biomarkers dosage. Variation factors assessed are:

  • Fasting condition
  • Sampling time
  • Sampling season
  • Physical activity
  • Duration and temperature of total blood treatment
  • Type of blood collection tube.

研究设计

研究类型
Observational
观察模型
Cohort

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged above 18 years.
  • Sign an informed consent after being informed
  • Able to follow the instructions of the study

排除标准

  • Serious associated diseases:
  • Severe liver disease
  • Renal failure
  • hepatitis B or C
  • Patient who are the subject of a judicial protection measure or under guardianship

结局指标

主要结局

Variation of serum and urine sample between baseline, weeks 2, 16, 52 and 68 to assess intra-individual biological variability of cartilage-specific biomarkers Coll2-1/Coll2-1NO2 / FIB3-1 and FIB3-2.

时间窗: Baseline and weeks 2, 16, 52 and 68

Change from baseline will be assess by biomarkers dosage using ELISA (Enzyme Linked ImmunoAssay)

次要结局

未报告次要终点

研究者

发起方
Artialis
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验